BiomX Inc. (PHGE)
NYSEAMERICAN: PHGE · IEX Real-Time Price · USD
0.450
+0.094 (26.40%)
Mar 28, 2024, 3:59 PM EDT - Market closed

BiomX Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016
Net Income
-28.32-36.23-30.09-20.56-12.72-6.43-1.9
Depreciation & Amortization
2.522.572.180.320.210.10.02
Share-Based Compensation
1.533.242.890.940.951.310.25
Other Operating Activities
-4.822.850.571.730.260.930.29
Operating Cash Flow
-29.09-27.57-24.45-17.58-11.3-4.1-1.34
Capital Expenditures
-0.11-3.68-1.01-1.31-0.14-0.85-0.1
Acquisitions
00000-0.110
Change in Investments
-219.85-9.8521.05-29.9-1.150
Investing Cash Flow
-2.1116.17-10.8619.74-30.04-2.12-0.1
Share Issuance / Repurchase
0.2923.060.211.88000
Debt Issued / Paid
014.2300001.2
Other Financing Activities
---0.0859.6743.0412.95-
Financing Cash Flow
0.2937.280.1361.5543.0412.951.2
Exchange Rate Effect
0.11-0.0300000
Net Cash Flow
-30.9125.88-35.1763.721.76.74-0.23
Free Cash Flow
-29.2-31.25-25.46-18.89-11.44-4.95-1.43
Free Cash Flow Per Share
-0.98-1.20-1.10-3.36-5.71-2.52-0.73
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).